95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.48%
Negative revenue growth while FNV stands at 2.23%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.48%
Negative gross profit growth while FNV is at 6.01%. Joel Greenblatt would examine cost competitiveness or demand decline.
219.35%
EBIT growth above 1.5x FNV's 19.38%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
219.35%
Operating income growth above 1.5x FNV's 8.68%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
311.06%
Net income growth above 1.5x FNV's 20.08%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
975.86%
EPS growth above 1.5x FNV's 17.43%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
975.86%
Diluted EPS growth above 1.5x FNV's 17.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
835.87%
OCF growth above 1.5x FNV's 48.94%. David Dodd would confirm a clear edge in underlying cash generation.
835.87%
Positive FCF growth while FNV is negative. John Neff would see a strong competitive edge in net cash generation.
7.47%
10Y revenue/share CAGR under 50% of FNV's 177.64%. Michael Burry would suspect a lasting competitive disadvantage.
7.47%
5Y revenue/share CAGR under 50% of FNV's 85.48%. Michael Burry would suspect a significant competitive gap or product weakness.
7.47%
3Y revenue/share CAGR 1.25-1.5x FNV's 6.49%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.39%
Negative equity/share CAGR over 10 years while FNV stands at 60.76%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.39%
Negative 5Y equity/share growth while FNV is at 27.88%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-24.39%
Negative 3Y equity/share growth while FNV is at 5.06%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.57%
Our AR growth while FNV is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-6.58%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.06%
Asset growth at 50-75% of FNV's 5.52%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.07%
Under 50% of FNV's 4.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-148.44%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.